NextPlat Corp. (NASDAQ:NXPL – Get Free Report) was the recipient of a large decline in short interest in the month of December. As of December 31st, there was short interest totaling 146,349 shares, a decline of 26.5% from the December 15th total of 199,110 shares. Approximately 1.0% of the company’s shares are sold short. Based on an average daily volume of 168,401 shares, the days-to-cover ratio is currently 0.9 days. Based on an average daily volume of 168,401 shares, the days-to-cover ratio is currently 0.9 days. Approximately 1.0% of the company’s shares are sold short.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of NextPlat in a research report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.
Check Out Our Latest Stock Analysis on NextPlat
Hedge Funds Weigh In On NextPlat
NextPlat Trading Up 1.3%
NextPlat stock traded up $0.01 during mid-day trading on Friday, hitting $0.73. The company’s stock had a trading volume of 30,287 shares, compared to its average volume of 129,326. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.80 and a current ratio of 3.56. The company has a 50 day moving average of $0.63 and a 200-day moving average of $0.73. NextPlat has a one year low of $0.43 and a one year high of $1.35. The stock has a market cap of $19.20 million, a PE ratio of -2.43 and a beta of 1.15.
NextPlat (NASDAQ:NXPL – Get Free Report) last issued its earnings results on Wednesday, November 12th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company had revenue of $13.75 million for the quarter. NextPlat had a negative net margin of 14.58% and a negative return on equity of 34.22%.
About NextPlat
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Featured Stories
- Five stocks we like better than NextPlat
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
